FDA
approval
· 2019-08-21
FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
Summary
The FDA approved AbbVie’s supplemental application for NORVIR (ritonavir). The approval updates the product’s labeling or uses as described in the submission.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORVIR (RITONAVIR)